Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03811795 · ClinicalTrials.gov registry record · NA
Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib
A NA study, sponsored by Valley Health System.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03811795 is a NA study that has completed, run by Valley Health System. The registered enrollment target is 9 participants.
The verdict
NCT03811795, a NA study, has completed, sponsored by Valley Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate whether cryoballoon ablation vs. radiofrequency ablation guided by high-fidelity mapping (Rhythmia) is the best treatment strategy to perform repeat ablation for recurrent atrial fibrillation after previously having undergone cryoballoon ablation.
Interventions
- OTHER ECG monitoring with a Kardia Mobile monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2022-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03811795
The ClinicalTrials.gov registry entry for NCT03811795 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Valley Health System, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ECG monitoring with a Kardia Mobile monitor is the first listed.
NCT03811795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03811795 about?
NCT03811795 is a clinical study titled "Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib". The purpose of this research is to evaluate whether cryoballoon ablation vs. radiofrequency ablation guided by high-fidelity mapping (Rhythmia) is the best treatment strategy to perform repeat ablation for recurrent atrial fibrillation after previously having undergone cryoballoon ablation.
What is the current status of trial NCT03811795?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-11-27. Estimated completion is 2022-04-26.
What interventions are being tested in trial NCT03811795?
The interventions under investigation include: ECG monitoring with a Kardia Mobile monitor (OTHER).
Who is sponsoring clinical trial NCT03811795?
This trial is sponsored by Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.